Catherine Mackey J.'s Insider Trades & SAST Disclosures
Catherine Mackey J.'s most recent trade in Avid Bioservices Inc was a trade of 26,756 Common Stock, $0.001 par value done . Disclosure was reported to the exchange on Dec. 14, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Catherine Mackey J..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avid Bioservices Inc | Catherine J. Mackey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 26,756 | 43,379 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Catherine J. Mackey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 26,756 | 0 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2024 | 8,147 | 8,147 | - | - | Restricted Stock Units | |
| Voyager Therapeutics Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 16,200 | 16,200 | - | - | Stock Option (right to buy) | |
| Avid Bioservices Inc | Mackey J. Catherine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 26,756 | 26,756 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Catherine Mackey J. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 9,612 | 0 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | J. Catherine Mackey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 9,612 | 16,623 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Ideaya Biosciences Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 16,200 | 16,200 | - | - | Stock Option (right to buy) | |
| Voyager Therapeutics Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Avid Bioservices Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 4,632 | 4,632 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Catherine J. Mackey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 2,379 | 2,379 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Catherine J. Mackey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 2,379 | 0 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2020 | 10,030 | 61,805 | - | - | Stock Option (right to buy) | |
| Avid Bioservices Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2020 | 2,379 | 2,379 | - | - | Restricted Stock Units | |
| Poseida Therapeutics Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges